Karen L. Zaderej - Aug 19, 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role: Director
Signature: /s/ Ron Honig, Attorney-in-Fact
Stock symbol: EYPT
Transactions as of: Aug 19, 2024
Transactions value $: $99,750
Form type: 4
Date filed: 8/21/2024, 04:01 PM
Previous filing: Jul 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EYPT	Common Stock	Purchase	$99.8K	+12.5K	+312.5%	$7.98	16.5K	Aug 19, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.13. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.13. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.